North Star Investment Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.91M Sell
57,457
-137
-0.2% -$15.8K 0.42% 48
2025
Q4
$6.06M Buy
57,594
+419
+0.7% +$39.3K 0.38% 55
2025
Q3
$4.8M Sell
57,175
-273
-0.5% -$22.5K 0.31% 73
2025
Q2
$4.55M Sell
57,448
-128
-0.2% -$10.2K 0.32% 69
2025
Q1
$5.17M Sell
57,576
-1,064
-2% -$99.3K 0.38% 54
2024
Q4
$5.83M Sell
58,640
-378
-0.6% -$39K 0.41% 56
2024
Q3
$6.7M Sell
59,018
-79
-0.1% -$9.39K 0.46% 51
2024
Q2
$7.32M Sell
59,097
-604
-1% -$77.8K 0.54% 41
2024
Q1
$7.88M Buy
59,701
+488
+0.8% +$60.1K 0.56% 36
2023
Q4
$6.46M Buy
59,213
+41
+0.1% +$4.26K 0.5% 46
2023
Q3
$6.09M Sell
59,172
-8,411
-12% -$907K 0.51% 44
2023
Q2
$7.8M Sell
67,583
-210
-0.3% -$23.8K 0.63% 30
2023
Q1
$7.21M Buy
67,793
+16,019
+31% +$1.73M 0.6% 36
2022
Q4
$5.74M Sell
51,774
-170
-0.3% -$17.4K 0.51% 38
2022
Q3
$4.47M Buy
51,944
+41
+0.1% +$3.66K 0.44% 55
2022
Q2
$4.73M Buy
51,903
+542
+1% +$48K 0.43% 57
2022
Q1
$4.21M Buy
51,361
+13
+0% +$1.02K 0.33% 75
2021
Q4
$3.94M Buy
51,348
+167
+0.3% +$13.3K 0.28% 83
2021
Q3
$3.84M Sell
51,181
-47
-0.1% -$3.58K 0.31% 78
2021
Q2
$3.98M Buy
51,228
+6,702
+15% +$498K 0.32% 81
2021
Q1
$3.27M Buy
44,526
+2,058
+5% +$152K 0.31% 88
2020
Q4
$3.31M Sell
42,468
-6,724
-14% -$514K 0.34% 75
2020
Q3
$3.89M Buy
49,192
+1,069
+2% +$83.7K 0.46% 56
2020
Q2
$3.55M Sell
48,123
-3,007
-6% -$226K 0.46% 58
2020
Q1
$3.75M Sell
51,130
-3,585
-7% -$282K 0.56% 45
2019
Q4
$4.75M Buy
54,715
+341
+0.6% +$28K 0.5% 57
2019
Q3
$4.37M Buy
54,374
+456
+0.8% +$36.5K 0.49% 53
2019
Q2
$4.31M Buy
53,918
+670
+1% +$51.3K 0.5% 49
2019
Q1
$4.23M Buy
53,248
+1,011
+2% +$75.6K 0.49% 49
2018
Q4
$3.81M Sell
52,237
-310
-0.6% -$21.9K 0.5% 50
2018
Q3
$3.56M Buy
52,547
+1,038
+2% +$66.1K 0.4% 63
2018
Q2
$2.98M Buy
51,509
+414
+0.8% +$23.4K 0.35% 77
2018
Q1
$2.66M Sell
51,095
-831
-2% -$44.9K 0.32% 80
2017
Q4
$2.79M Sell
51,926
-901
-2% -$50K 0.34% 77
2017
Q3
$3.23M Sell
52,827
-613
-1% -$37.2K 0.41% 67
2017
Q2
$3.27M Buy
53,440
+1,092
+2% +$66.5K 0.44% 60
2017
Q1
$3.17M Sell
52,348
-142
-0.3% -$8.62K 0.44% 60
2016
Q4
$2.95M Sell
52,490
-15,730
-23% -$921K 0.44% 59
2016
Q3
$4.06M Buy
68,220
+845
+1% +$49.4K 0.72% 25
2016
Q2
$3.7M Sell
67,375
-459
-0.7% -$24.4K 0.68% 27
2016
Q1
$3.42M Sell
67,834
-8,645
-11% -$423K 0.66% 33
2015
Q4
$3.85M Buy
76,479
+14,824
+24% +$747K 0.75% 25
2015
Q3
$2.91M Buy
61,655
+23,638
+62% +$1.26M 0.6% 37
2015
Q2
$2.06M Hold
38,017
0.38% 83
2015
Q1
$2.08M Sell
38,017
-896
-2% -$50.7K 0.39% 72
2014
Q4
$2.11M Buy
38,913
+322
+0.8% +$17.9K 0.4% 76
2014
Q3
$2.18M Sell
38,591
-740
-2% -$41.6K 0.44% 65
2014
Q2
$2.17M Buy
39,331
+283
+0.7% +$15.4K 0.44% 58
2014
Q1
$2.12M Buy
39,048
+333
+0.9% +$17.2K 0.44% 60
2013
Q4
$1.85M Buy
38,715
+6,812
+21% +$311K 0.4% 61
2013
Q3
$1.45M Sell
31,903
-6,393
-17% -$292K 0.39% 69
2013
Q2
$1.7M Buy
+38,296
New +$1.71M 0.44% 58

Other funds holding MRK

North Star Investment Management's MRK Position: Q1 2026 in Review

North Star Investment Management reduced its Merck (MRK) stake by 0.24% in Q1 2026, selling an estimated $15.8K and leaving 57,457 shares worth $6.91M. The position accounts for 0.42% of the portfolio, ranked #48.

North Star Investment Management first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $7.88M in Q1 2024. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • North Star Investment Management held 57,457 shares of Merck worth $6.91M as of Q1 2026.
  • North Star Investment Management sold 137 Merck shares in Q1 2026, an estimated $15.8K.
  • Merck made up 0.42% of North Star Investment Management's portfolio in Q1 2026, its #48 holding.
  • North Star Investment Management first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • North Star Investment Management's Merck position peaked at $7.88M in Q1 2024.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on North Star Investment Management's 13F filing for Q1 2026, filed 23 Apr 2026.